Web Exclusives

Basal-cell carcinoma targeted by new deoxyribozyme drug

A new class of drugs targeting the genetic material of skin cancer has been successfully tested in humans for the first time. This opens the way to new treatments for a range of conditions from skin cancers to eye diseases.

FDA wants warning labels on tanning devices

The FDA is proposing that indoor tanning beds and booths carry labels that warn minors not to use these products.

Sleep problems may increase risk for prostate cancer

Men who reported sleep problems, including difficulty falling asleep and staying asleep, had up to a twofold increased risk for prostate cancer, according to recently published data.

Bladder cancer could recur despite bladder removal

Additional therapy may be needed for patients with advanced bladder cancers that are surgically removed. A five-year, international study validated the use of a marker panel to predict which patients are more likely to have a recurrence of cancer after bladder removal.

Statin use may reduce deaths from prostate cancer

Men with prostate cancer who used statin drugs prior to diagnosis had a decreased risk of prostate-cancer-specific mortality.

Thoracic endografts successfully remove tumors invading the aorta

Placing a stent within the aorta facilitated the subsequent removal of a tumor in the aorta and eliminated the need for heart-lung bypass for research patients.

New prostate cancer test improve risk assessment

A new tool helps identify men who are best suited for active surveillance of prostate cancer, predicting which are more likely to harbor an aggressive form of the disease.

Time to tumor growth best predicts survival in colorectal cancer

Time to tumor growth proved to be the best metric for predicting overall survival in persons with metastatic colorectal cancer on bevacizumab.

Cancer biorepository speeds clinical trials and drug development

A warehouse of patient-donated biological data expedites trial accrual, reduces trial sizes, saves money, and may speed drugs through the drug development pipeline.

Scientific basis for cognitive complaints of breast cancer patients found

A new study shows a significant correlation between poorer performance on neuropsychological tests and memory complaints in posttreatment, early-stage breast cancer patients—particularly those who have undergone combined chemotherapy and radiation.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs